Navigation Links
Scientists film inner workings of the immune system
Date:12/3/2008

which could lead to better vaccines."

"On the other side of the story, scientists can now visualise the pathway of current vaccines in the immune system, providing greater understanding and the potential for refining current interventions against disease."

Centenary Institute Executive Director, Professor Mathew Vadas, says the multi-photon microscope used to film this immune process is the Hubble telescope of medical research.

"The Hubble allowed the universe to be seen with absolute clarity, which wasn't before possible from earth," he explains. "This is exactly the same as multi-photon microscopy it provides a unique and innovative view of cells, unveiling a whole new understanding of how immune processes work."


'/>"/>

Contact: Erin Sharp
e.sharp@centenary.org.au
61-295-656-118
Research Australia
Source:Eurekalert

3

GOOD

Page: 1 2

Related biology news :

1. Rooted plants move mysteriously down greenways, scientists say
2. Caltech scientists show function of helical band in heart
3. Argonne scientists discover possible mechanism for creating handedness in biological molecules
4. Scientists developing food allergy treatment
5. Wistar scientists find key to keeping killer T cells in prime shape for fighting infection, cancer
6. CSHL scientists discover a new way in which epigenetic information is inherited
7. Caltech scientists develop barcode chip for cheap, fast blood tests
8. UNC scientists teach enzyme to make synthetic heparin in more varieties
9. Childrens Hospital scientists achieve repair of injured heart muscle in lab tests of stem cells
10. Scientists shed light on evolution of gene regulation
11. Scientists build roach motel for nasty bugs of the bacterial variety
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2